Litigation for FASLODEX

US Court Litigation for FASLODEX

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
6,774,122		1:15-cv-00183|N.D.W. Va.	2015-10-15	2017-01-04	35:271 Patent Infringement	District Court, N.D. West Virginia	None
6,774,122		1:15-cv-06039|D.N.J.	2015-08-06	2017-10-27	35:271 Patent Infringement	District Court, D. New Jersey	None
6,774,122		1:15-cv-07009|D.N.J.	2015-09-21	2015-12-07	35:271 Patent Infringement	District Court, D. New Jersey	None
6,774,122	SAGENT PHARMACEUTICALS, INC. v. GLENMARK GENERICS INC	1:15-mc-00938|D.C.	2015-07-22		Motion to Compel	District Court, District of Columbia	None
6,774,122	SAGENT PHARMACEUTICALS, INC. v. GLENMARK GENERICS INC	1:15-mc-00938|D.D.C.	2015-07-22		Motion to Compel	District Court, District of Columbia	None
6,774,122	AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC	1:16-cv-00669|D. Del.	2016-08-05	2016-11-04	35:0145	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for FASLODEX

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
6,774,122	Mylan Pharmaceuticals Inc.		2016-06-29	06-29-2016		Inter partes review			John Evans
6,774,122	InnoPharma Licensing LLC et al.		2017-02-17	02-17-2017		Inter partes review		08-30-2017
6,774,122	Fresenius Kabi USA,LLC		2017-08-04	08-04-2017	Evans et al	Inter partes review		12-11-2017
7,456,160	Mylan Pharmaceuticals Inc.		2016-06-29	06-29-2016		Inter partes review			John Evans
8,329,680	Mylan Pharmaceuticals Inc. et al.		2016-06-29	06-29-2016		Inter partes review		12-14-2016	John Evans
8,329,680	InnoPharma Licensing LLC et al.		2017-02-17	02-17-2017		Inter partes review		08-30-2017